We examined the behavior of these mammary carcinomas in mice carrying targeted deletions of Ccl2 or Ccr2, as well as wild type mice treated with a small molecule antagonist of CCR2, and explored the effects of this chemokine ligand/receptor pair on the tumor microenvironment. The gene discussed is CCL2; the disease is neoplasm.